JAS239, a newly developed carbocyanine dye, can inhibit the activity of choline kinase alpha (ChoK) in breast cancer cells, leading to cell death, and it has the potential to be used as a companion diagnostic tool for noninvasive breast tumor staging and as a novel treatment for aggressive, therapy-resistant tumors. This evidence concerns the gene CHKA and breast carcinoma.